Is a complete ERNA research report available?

No complete published report is available for Ernexa Therapeutics Inc. (ERNA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Ernexa Therapeutics Inc. (ERNA)

NASDAQ: ERNA · USD

$3.47

+0.06 (+1.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ERNA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4M
Net income (ttm)	-11.4M
EPS (ttm)	-$27.5
Shares out	1.2M
Volume	35,597
Beta	2.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.4M
EPS (ttm): -$27.5
Market cap: 4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ERNA indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000748592
Company name	Ernexa Therapeutics Inc.
Country	United States
Country code	US
Cusip	114082407
Employees	7
Employees Change	1%
Employees Change Percent	16.67
Enterprise value	$-4.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US1140824079
Last refreshed	2026-07-31
Market cap	$4M
Market cap category	Nano-Cap
Price	$3.47
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	ERNA
Website	https://www.ernexatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-287.58%
FCF yield	-182.95%
P/B ratio	0.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-11.4M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	$-1.6M
ROA	-81.2
Roa5y	-64.23
ROCE	-171.9
ROE	-2,505.6
Roe5y	-824.6
ROIC	-303.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.26%
Cagr3y	-85.08%
Cagr5y	-86.85%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$10.5M
Cash	$9.2M
Current Assets	$10M
Current Liabilities	$3.5M
Debt	$389,000
Debt Equity	$0.06
Equity	$6.9M
Interest Coverage	-451
Liabilities	$3.7M
Long Term Assets	$547,000
Long Term Liabilities	$227,000
Net Cash	$8.8M
Net Cash By Market Cap	$222
Net Debt Equity	$-1.28
Tangible Book Value	$6.9M
Tangible Book Value Per Share	$5.88
WACC	16.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.89
Net Working Capital	$-2.5M
Quick ratio	2.68
Working Capital	$6.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-507.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.25%
200-day SMA	17.25
3Y total return	-99.67%
50-day SMA	6.99
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	605,024.7
All Time High Change	-100%
All Time High Date	2021-05-03
All Time Low	3.18
All Time Low Change	9.02%
All Time Low Date	2026-05-04
ATR	0.74
Beta	2.51
Beta1y	3.32
Beta2y	1.83
Ch YTD	-88.43
High	3.55
High52	71.5
High52 Date	2025-10-29
High52ch	-95.15%
Low	3.36
Low52	3.18
Low52 Date	2026-05-04
Low52ch	9.02%
Ma50ch	-50.34%
Premarket Change Percent	0
Premarket Price	$3.41
Premarket Volume	2,098
Price vs 200-day SMA	-79.88%
RSI	30.26
RSI Monthly	47.51
RSI Weekly	32.1
Sharpe ratio	-0.95x
Sortino ratio	-1.5
Total Return	-507.35%
Tr YTD	-88.43
Tr1m	-50.64%
Tr1w	-13.03%
Tr3m	-25.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-3.3
Operating Income	$-10.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	668,713%
Float Percent	57.33%
Shares Insiders	35.68%
Shares Institutions	7.27%
Shares Out	1,166,333
Shares Qo Q	139.8%
Shares Yo Y	507.35%
Short Float	2.2%
Short Ratio	0.01
Short Shares	1.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.6M
Adjusted OCF	-8,519,000
Average Volume	1,378,586.2x
Bv Per Share	5.88
CAPEX	$-39,000
Ch1m	-50.64
Ch1w	-13.03
Ch1y	-92.25
Ch3m	-25.93
Ch3y	-99.67
Ch5y	-100
Ch6m	-88.43
Change	1.76%
Change From Open	0.58
Close	3.41
Days Gap	1.17
Depreciation Amortization	55,000
Dollar Volume	123,521.6
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-12.2M
EBITDA	$-12.1M
EPS	$-27.49
F Score	2
FCF	$-7.3M
FCF EV Yield	150.44x
FCF Per Share	$-6.22
Financing CF	14,514,000
Fiscal Year End	December
Founded	2,018
Income Tax	$-93,000
Investing CF	-39,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2026-05-04
Last Split Type	Reverse
Last10k Filing Date	2026-03-13
Ma150	11.39
Ma150ch	-69.52%
Ma20	5.26
Ma20ch	-34.07%
Net CF	7,259,000
Next Earnings Date	2026-08-12
Open	3.45
Optionable	No
Position In Range	58.33
Post Close	3.47
Postmarket Change Percent	-1.73
Postmarket Price	$3.41
Ppne	437,000
Pre Close	3.41
Price Date	2026-07-30
Ptbv Ratio	0.58
Relative Volume	0.03x
Share Based Comp	1,303,000
Tr6m	-88.43%
Us State	Massachusetts
Volume	35,597

Ernexa Therapeutics Inc. (ERNA)

Coverage state: Market snapshot only — no published research

Generate the first ERNA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ERNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ERNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ERNA

Frequently asked questions